(Q24240459)

26 October 2023

1

David A Grimes

David A

Grimes

1 reference

26 October 2023

Paul A O'Brien

3

Paul A

O'Brien

1 reference

20091638

26 October 2023

Elizabeth G. Raymond

series ordinal

4

author given names

Elizabeth G

author last names

Raymond

1 reference

20091638

Cochrane Database of Systematic Reviews

26 October 2023

publication date

20 January 2010

0 references

published in

0 references

cites work

A novel estrogen-free oral contraceptive pill for women: multicentre, double-blind, randomized controlled trial of mifepristone and progestogen-only pill (levonorgestrel).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

Maintenance of ovulation inhibition with the 75-microg desogestrel-only contraceptive pill (Cerazette) after scheduled 12-h delays in tablet intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

Desogestrel-only pill (Cerazette).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

FFPRHC Guidance (July 2004): Contraceptive choices for breastfeeding women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

Surrogate end points in clinical research: hazardous to your health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

Hormonal contraception and risk of venous thromboembolism: national follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

Immediate start of hormonal contraceptives for contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

Steroid hormones for contraception in women with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

A comparative study of a progestin-only oral contraceptive versus non-hormonal methods in lactating women in Buenos Aires, Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

Allocation concealment in randomised trials: defending against deciphering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

Sample size slippages in randomised trials: exclusions and the lost and wayward

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

Triphasic versus monophasic oral contraceptives for contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

7 January 2021

A andomized contraceptive trial comparing a daily progestogen with a combined oral contraceptive steroid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

7 January 2021

A randomized, double-blind study of two combined and two progestogen-only oral contraceptives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

7 January 2021

A multicenter clinical trial of a progestin-only oral contraceptive in lactating women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

7 January 2021

RANDOMISED DOUBLE-BLIND TRIAL OF FOUR ORAL PROGESTAGEN-ONLY CONTRACEPTIVES

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

7 January 2021

A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

7 January 2021

A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Collaborative Study Group on the Desogestrel-containing P

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007541.PUB2

7 January 2021

10.1002/14651858.CD007541.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_5ph7wrhaxrhodi7csnu2wccove

0 references